TrialThe Journal of clinical endocrinology and metabolism2016

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).

J N Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.